Home/Filings/4/0001209191-11-008872
4//SEC Filing

Walsh Christopher James 4

Accession 0001209191-11-008872

CIK 0000731766other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 4:30 PM ET

Size

7.8 KB

Accession

0001209191-11-008872

Insider Transaction Report

Form 4
Period: 2011-02-09
Walsh Christopher James
EVP and General Counsel
Transactions
  • Tax Payment

    Common Stock

    2011-02-09$42.07/sh1,239$52,12563,499 total
  • Award

    Common Stock

    2011-02-09+23,77087,269 total
Footnotes (2)
  • [F1]The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014.
  • [F2]Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 23,770.

Issuer

UNITEDHEALTH GROUP INC

CIK 0000731766

Entity typeother

Related Parties

1
  • filerCIK 0001475141

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:30 PM ET
Size
7.8 KB